These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 6462747

  • 21. [Pharmacokinetic studies on intravenous drip infusion of dibekacin in elderly subjects without apparent renal failure (author's transl)].
    Sawae Y, Okada K, Umemura K.
    Jpn J Antibiot; 1982 Mar; 35(3):770-8. PubMed ID: 7097979
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of dibekacin after intramuscular administration in man.
    Umemura K, Komiya I, Nakadori S, Chow SY.
    Jpn J Antibiot; 1977 Sep; 30(9):650-6. PubMed ID: 916185
    [Abstract] [Full Text] [Related]

  • 23. In vitro activity and clinical evaluation of cefixime in urinary tract infection.
    Asvanich K, Fugpholngam V, Srimuang S, Tanphaichitra D.
    J Med Assoc Thai; 1998 Apr; 81(4):301-4. PubMed ID: 9623027
    [Abstract] [Full Text] [Related]

  • 24. [Dibekacin in the treatment of septicemia].
    Becq-Giraudon B, Auboyer D, Auvinet B, Basse F, Brenez M, Casanova P, Gouin F, Gouzi JL, Groussin P, Legendre P, Le Menn G, Liozon F, Pauchant M, Remy G, Robert D, Vallat C, Vedel M.
    Nouv Presse Med; 1982 Nov 18; 11(46):3439-43. PubMed ID: 7155854
    [Abstract] [Full Text] [Related]

  • 25. [Clinical evaluation of azthreonam in severe urinary tract infections].
    Guibert J, Acar JF, Miegi M.
    Pathol Biol (Paris); 1984 May 18; 32(5):446-9. PubMed ID: 6377208
    [Abstract] [Full Text] [Related]

  • 26. [Clinical studies on dibekacin for infectious diseases following intramuscular and intravenous drip administration. Concentration in infected tissues and clinical responses (author's transl)].
    Nakamura T, Hashimoto I, Sawada Y, Mikami J, Bekki E, Kasai Y, Nakanishi M.
    Jpn J Antibiot; 1981 Jun 18; 34(6):980-93. PubMed ID: 7289045
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of an antibiotic coated indwelling catheter: a preliminary report.
    Sakamoto I, Umemura Y, Nakano H, Nihira H, Kitano T.
    J Biomed Mater Res; 1985 Jun 18; 19(9):1031-41. PubMed ID: 3910651
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.
    Goto M, Sugiyama M, Ishizaki T.
    Antimicrob Agents Chemother; 1980 Sep 18; 18(3):372-6. PubMed ID: 6775594
    [Abstract] [Full Text] [Related]

  • 29. [Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin].
    Bopp S, Marre R, Schulz E, Sack K.
    Arzneimittelforschung; 1981 Sep 18; 31(3):473-7. PubMed ID: 7194672
    [Abstract] [Full Text] [Related]

  • 30. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Palatnik LP, Johnson J, Noreddin A, Harding GK, Nicolle LE, Hoban DJ, NAUTICA Group.
    Int J Antimicrob Agents; 2005 Nov 18; 26(5):380-8. PubMed ID: 16243229
    [Abstract] [Full Text] [Related]

  • 31. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L, Gunzer F, Ziesing S, Pape A, Offner G, Ehrich JH.
    Klin Padiatr; 2004 Nov 18; 216(2):83-6. PubMed ID: 15106080
    [Abstract] [Full Text] [Related]

  • 32. Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infections.
    Casellas JM, Tome G, Exeni R, Grimoldi I, Goldberg M, Farinati AE.
    Pathol Biol (Paris); 1993 Apr 18; 41(4):385-91. PubMed ID: 8233640
    [Abstract] [Full Text] [Related]

  • 33. Clinical experience with an aminoglycoside antibiotic, dibekacin, in the treatment of infectious diseases in obstetric and gynecological field .
    Takabatake H, Nishino R, Shiina M, Satoh Y, Ohno T, Ohmae T, Moriyama H.
    Jpn J Antibiot; 1979 Mar 18; 32(3):375-86. PubMed ID: 439409
    [No Abstract] [Full Text] [Related]

  • 34. Diagnosis, treatment and registration of urinary tract infections in geriatric patients.
    Friis-Møller A, Lüneborg-Nielsen M.
    Ann Univ Mariae Curie Sklodowska Med; 2002 Mar 18; 57(1):540-3. PubMed ID: 12898972
    [Abstract] [Full Text] [Related]

  • 35. [Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections].
    Soejima R, Niki Y, Matsushima T, Tano Y.
    Jpn J Antibiot; 1982 Dec 18; 35(12):2773-7. PubMed ID: 7182533
    [No Abstract] [Full Text] [Related]

  • 36. Etiologies of the urinary tract infections in a Yemeni City.
    Nasher MA, Nasher TM, Gunaid AA.
    Saudi Med J; 2001 Jul 18; 22(7):599-602. PubMed ID: 11479641
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of dibekacin in children with cystic fibrosis.
    Courcol RJ, Loeuille GA, Delnatte J, Martin GR.
    Int J Clin Pharmacol Res; 1985 Jul 18; 5(2):87-91. PubMed ID: 4018945
    [Abstract] [Full Text] [Related]

  • 38. [Pharmacokinetics of dibekacin in subjects with normal renal function].
    Thauvin C, Borsa F, Leroy A, Humbert G.
    Nouv Presse Med; 1982 Nov 18; 11(46):3410-3. PubMed ID: 7155848
    [Abstract] [Full Text] [Related]

  • 39. [In vitro antibacterial activity of dibekacin on staphylococci, streptococci and aerobic Gram negative bacilli].
    Deforges L, Van Thoi J, Le Soussy CJ, Duval J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3385-90. PubMed ID: 7155845
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.